Opioid addiction is treatable, and the most effective approach combines medication with behavioral support. Around 7.8 million people in the United States misused opioids in the past year, and treatment has evolved significantly. The biggest shift in recent years: any licensed prescriber can now offer buprenorphine without a special waiver, making medication far more accessible than it used to be.
Medications That Reduce Cravings and Withdrawal
Medication is the cornerstone of opioid addiction treatment. Three FDA-approved options work in different ways on the brain’s opioid receptors, and choosing between them depends on your circumstances, preferences, and how long you’ve been opioid-free.
Methadone
Methadone fully activates the same brain receptors that heroin and prescription opioids target, but it does so slowly and steadily. At the right dose, it stops withdrawal symptoms and reduces cravings without producing the intense high of shorter-acting opioids. The tradeoff is that methadone can only be dispensed through licensed opioid treatment programs, which typically require daily in-person visits, at least at first. Over time, patients who demonstrate stability can earn take-home doses. Because methadone is a full activator of opioid receptors, overdose is possible if the dose is too high or if it’s combined with other sedating substances.
Buprenorphine
Buprenorphine only partially activates opioid receptors. It quiets withdrawal and cravings but has a built-in ceiling: beyond a certain dose, its effects plateau. This makes it significantly harder to overdose on compared to methadone, and it has less impact on breathing. If someone uses heroin or another opioid while taking buprenorphine, the rewarding high is blunted because buprenorphine holds tightly to the receptor and blocks other opioids from fully binding.
Since late 2022, the old requirement for doctors to obtain a special “X-waiver” before prescribing buprenorphine has been eliminated. Any practitioner with an appropriate state license can now prescribe it, and the previous cap of 275 patients has been removed. Initial evaluations can even happen over telehealth, including audio-only calls when video isn’t available. This means you can often start treatment through a primary care office or telehealth service rather than a specialized clinic.
Naltrexone
Naltrexone works the opposite way. Instead of activating opioid receptors, it blocks them entirely. If you take an opioid while on naltrexone, you won’t feel any euphoria or pain relief. It doesn’t create physical dependence and produces none of the pleasurable effects of opioids. The monthly injectable form removes the daily decision of whether to take a pill.
The catch: you must be completely opioid-free for 7 to 10 days before starting naltrexone. If you’re transitioning from methadone or buprenorphine, that window extends to about two weeks. Taking naltrexone too soon triggers precipitated withdrawal, an intense, rapid-onset version of withdrawal that can be severe. This opioid-free gap is the biggest practical barrier to starting naltrexone, and it’s why many people relapse during the transition period.
What Withdrawal Feels Like and How Long It Lasts
For heroin and short-acting opioids, physical withdrawal symptoms typically start 6 to 12 hours after the last dose. They peak around days two and three, then gradually ease over roughly five days. Symptoms include muscle aches, nausea, diarrhea, sweating, anxiety, and insomnia. It feels like a bad flu combined with intense restlessness and agitation.
Withdrawal from longer-acting opioids like methadone takes longer to begin and can stretch over two weeks or more. While opioid withdrawal is rarely life-threatening on its own, the discomfort is severe enough that it drives many people back to using. This is exactly why starting medication (particularly buprenorphine or methadone) before or during withdrawal improves the odds of staying in treatment. Buprenorphine can be started once early withdrawal symptoms appear, often within 12 to 24 hours of the last opioid dose, providing rapid relief.
Behavioral Therapy Alongside Medication
Medication handles the physical side of addiction. Behavioral therapy addresses the patterns, triggers, and emotional factors that keep the cycle going. The combination consistently outperforms either approach alone.
Cognitive behavioral therapy helps you identify the thoughts and situations that lead to use and develop concrete strategies for responding differently. It’s widely available in both individual and group formats.
Contingency management, which uses tangible rewards (vouchers, small payments, or privileges) for meeting treatment goals like clean drug tests, has some of the strongest evidence behind it. In one study, participants receiving incentives were nearly twice as likely to submit opioid-negative urine samples compared to those on methadone alone. Treatment retention rates in contingency management groups consistently run 10 to 15 percentage points higher than standard care. One trial found 85% of participants in an incentive-based group completed 12 weeks of treatment versus 76% in standard treatment. Another showed 81% retention with incentives compared to 67% with usual care.
These aren’t small differences. Staying in treatment longer is one of the strongest predictors of long-term recovery, and even modest increases in retention translate to better outcomes months and years later.
Mental Health Conditions and Addiction Together
Depression, anxiety, PTSD, and other mental health conditions frequently overlap with opioid addiction. People with both conditions are more than twice as likely to have repeated hospital visits (37.7% vs. 16.1% for those without co-occurring conditions) and face higher mortality rates at every follow-up interval after hospital discharge. They’re also nearly three times as likely to leave treatment against medical advice during a hospitalization.
Treating both conditions simultaneously produces better results than addressing them separately. If you’re dealing with anxiety or depression alongside opioid use, look for programs that integrate psychiatric care with addiction treatment rather than treating them as unrelated problems. Many outpatient programs and opioid treatment programs now offer this kind of combined approach.
Treatment Settings
Most people with opioid addiction can be treated effectively as outpatients, especially when medication is part of the plan. Outpatient treatment lets you maintain work, family, and daily responsibilities while attending regular appointments for medication management and counseling.
Residential or inpatient programs are better suited for people who have unstable housing, severe co-occurring mental health conditions, repeated relapses in outpatient settings, or who need a structured environment to get through the initial stabilization period. Intensive outpatient programs offer a middle ground, with multiple sessions per week but no overnight stay.
The setting matters less than what happens within it. Programs that combine medication with behavioral support and treat the full picture, including mental health, consistently produce the best outcomes regardless of whether they’re inpatient or outpatient.
Naloxone as a Safety Net
Naloxone reverses opioid overdoses within minutes and is now available over the counter in most pharmacies. It’s a temporary rescue tool, not a treatment for addiction, but carrying it saves lives during the vulnerable periods of early recovery and any point where relapse is possible. Community-level increases in naloxone availability have been linked to roughly 6 to 9% reductions in overdose deaths, depending on how distribution programs are structured. If you or someone close to you is in treatment or actively using, keeping naloxone on hand is a straightforward precaution.
Starting Treatment
The fastest path into treatment depends on what’s available near you. Buprenorphine can be prescribed by any licensed provider, so a call to your primary care doctor or a telehealth addiction service is often the simplest first step. For methadone, you’ll need to locate a licensed opioid treatment program. SAMHSA’s treatment locator (findtreatment.gov) maps both options by zip code.
There’s no requirement to hit a certain low point before treatment works. People who start medication earlier in the course of addiction generally do better, and the removal of prescribing barriers means fewer hoops to jump through than even a few years ago. Recovery rates improve substantially with each month a person stays on medication, which is why current guidelines favor long-term or indefinite medication use over short tapers for most people with opioid addiction.